A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| 8arm-PEG20K-Succinimidyl Succinate | 8arm-PEG20K-Succinimidyl Succinate. Group: Poly(ethylene glycol) and poly(ethylene oxide). |  |
| 8arm-PEG20K-Vinylsulfone, tripentaerythritol core | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 8arm-PEG-VS, 8arm-PEG-Vinylsulfone, tripentaerythritol core. Molecular formula: average Mn 20000. | |
| 8arm-PEG20K-Vinylsulfone, tripentaerythritol core | average Mn 20,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). |  |
| 8arm-PEG40K-COOH | hexaglycerol core, average Mn 40,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG40K-COOH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 8arm-PEG-COOH. Molecular formula: average Mn 40000. | |
| 8arm-PEG40K-Maleimide | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 8arm-PEG-Maleimide. Molecular formula: average Mn 40000. | |
| 8arm-PEG40K-Maleimide | hexaglycerol core, average Mn 40,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG40K-NH2 | hexaglycerol core, HCl Salt, average Mn 40,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG40K-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 8arm-PEG-NH2. Molecular formula: average Mn 40000. | |
| 8arm-PEG40K-Succinimidyl Glutarate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 40000. | |
| 8arm-PEG40K-Succinimidyl Glutarate | Hexaglycerol core, average Mn 40000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG40K-Succinimidyl Succinate | Hexaglycerol core, average Mn 40000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG40K-Succinimidyl Succinate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 40000. | |
| 8-arm PEG5K-Acrylate (hexaglycerol core) | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 5000. | |
| 8-arm PEG5K-Acrylate (tripentaerythritol core) | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 5000. | |
| 8-arm PEG5K-Methacrylate (hexaglycerol core) | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 5000. | |
| 8-arm PEG5K-Methacrylate (tripentaerythritol core) | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 5000. | |
| 8-arm PEG5K-PCL1K-Acrylate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8-arm PEG5K-PLA1K-Acrylate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). ≥95%. | |
| 8-Arm PEG-Biotin, MW 10k-40K | The 8-arm PEG derivative has a larger molecular weight and can carry more drug molecules. The 8-arm PEG derivative has a branched or comb-like structure. Multi-arm PEG derivatives are commonly used in drug delivery systems. The molecular weight of the modified drug is increased and is not easily eliminated by metabolism in the body. In addition, the dispersibility and solubility of the modified drug in the body are improved. Multi-arm PEG derivatives can also modify the surface of biological materials or form new biomedical materials. Mole weight: Customizable. |  |
| 8-Arm PEG-DBCO | 8-Arm PEG-DBCO. Uses: Designed for use in research and industrial production. Purity: 0.9. Product ID: ACMA00006129. Alfa Chemistry ISO 9001:2015 Certified. |  |
| 8-Aza-2,6-diaminopurine sulfate | 8-Aza-2,6-diaminopurine sulfate. Group: Biochemicals. Grades: Highly Purified. CAS No. 65591-11-9. Pack Sizes: 1g, 5g, 10g. Molecular Formula: C4H5N7·O4S. US Biological Life Sciences. |  Worldwide |
| 8-Aza-2'-beta-C-methylguanosine | 8-Aza-2'-beta-C-methylguanosine: One compound, with a rather intricate name - 8-Aza-2'-beta-C-methylguanosine, finds significant application in the biomedical sector for research and development. In fact, scientists readily exploit its synthetic forerunner role while manufacturing a range of antiviral medications targeting RNA viruses, an area of paramount importance. Its unmatched constitution and characteristics render it an indispensable asset in the realm of drug exploration and medicinal chemistry, fostering the battle against debilitating viral afflictions. Grade: ≥95%. Molecular formula: C10H14N6O5. Mole weight: 298.26. | |
| 8-Aza-2'-deoxyadenosine | 8-Aza-2'-deoxyadenosine, a potent compound widely employed in the biomedical sector, exhibits immense potential for the treatment of diverse malignancies, notably leukemia and lymphoma. Its efficacy lies in its ability to impede DNA and RNA synthesis, culminating in the robust suppression of tumor proliferation. As a pivotal research asset, this nucleoside analog enables in-depth elucidation of oncogenic mechanisms and facilitates the innovative formulation of therapeutic interventions. Molecular formula: C9H12N6O3. Mole weight: 252.23. | |
| 8-Aza-5'-AMP | 8-Aza-5'-AMP, a nucleoside analog, has been widely employed in exploring the activity of purine nucleoside phosphorylase (PNP) and its role in immune system functionality. Moreover, it maintains immense potential for conducting experiments on T-cell depletion and treating severe ailments like autoimmune diseases and cancer. Synonyms: 8- Azaadenosine- 5'- O- monophosphate. Molecular formula: C9H13N6O7P (free acid). Mole weight: 348.2 (free acid). | |
| 8-Aza-7-deaza-2'-deoxyadenosine (4-Amino-1-(2-deoxyribofuranosyl)pyrazolo[3,4-d]-pyrimidine) | 8-Aza-7-deaza-2'-deoxyadenosine (4-Amino-1-(2-deoxyribofuranosyl)pyrazolo[3,4-d]-pyrimidine), an extensively researched and scientifically proven potent anticancer drug, demonstrates exceptional efficacy in impeding DNA synthesis and growth of cancer cells. This remarkable compound exhibits impressive results in precisely targeting and inhibiting cancer progression, positioning itself as an invaluable asset within the realm of biomedicine. Grade: ≥ 95%. CAS No. 17318-21-7. Molecular formula: C10H13N5O3. Mole weight: 251.24. | |
| 8-Aza-7-deaza-2'-deoxyguanosine | 8-Aza-7-deaza-2'-deoxyguanosine, an indispensable component, significantly contributes to the advancement of antiviral pharmaceuticals aimed at countering ailments engendered by DNA viruses, including herpes simplex virus (HSV) and varicella-zoster virus (VZV). Its paramount function lies in impeding viral duplication through the disruption of viral DNA synthesis. Grade: ≥ 95%. CAS No. 100644-70-0. Molecular formula: C10H13N5O4. Mole weight: 267.24. | |
| 8-Aza-7-deaza-2'-deoxyguanosine | 8-Aza-7-deaza-2'-deoxyguanosine. Group: Biochemicals. Grades: Highly Purified. CAS No. 100644-70-0. Pack Sizes: 5mg, 10mg, 25mg, 50mg, 100mg. Molecular Formula: C10H13N5O4. US Biological Life Sciences. | Worldwide |
| 8-Aza-7-deaza-2'-deoxy-N2-DMF-5'-O-DMT-guanosine 3'-CE phosphoramidite | 8-Aza-7-deaza-2'-deoxy-N2-DMF-5'-O-DMT-guanosine 3'-CE phosphoramidite is a remarkably efficient phosphoramidite building block employed in solid-phase research and development, facilitating the generation of modified RNA or DNA oligonucleotides. Through its incorporation, 8-aza-7-deaza modifications are introduced. Synonyms: 5'-Dimethoxytrityl-N-dimethylformamidine-8-aza-7-deaza-2'-deoxyGuanosine, 3'-[(2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite; 7-Deaza-8-aza-dG-CE Phosphoramidite (PPG). Grade: 95%. CAS No. 500891-26-9. Molecular formula: C43H53N8O7P. Mole weight: 824.91. | |
| 8-Aza-7-deaza-2'-deoxy-N2-DMF-5'-O-DMT-guanosine 3'-CE phosphoramidite | 8-Aza-7-deaza-2'-deoxy-N2-DMF-5'-O-DMT-guanosine 3'-CE phosphoramidite. Group: Biochemicals. Grades: Highly Purified. CAS No. 500891-26-9. Pack Sizes: 100mg, 250mg. Molecular Formula: C43H53N8O7P. US Biological Life Sciences. | Worldwide |
| 8-Aza-7-deaza-A CEP | 8-Aza-7-deaza-A CEP is a vital compound used in the biomedical industry. With its unique chemical properties, it plays a crucial role in the synthesis of drugs targeting various diseases. This product is extensively utilized in the research and development of pharmaceuticals aimed at treating cancer, viral infections, and neurological disorders. Molecular formula: C53H66N7O8PSi. Mole weight: 988.19. | |
| 8-Aza-7-deaza-A-CE Phosphoramidite | 8-Aza-7-deaza-A-CE Phosphoramidite, a chemical compound utilized for oligonucleotide synthesis, is a powerful tool for modifying nucleic acid structures in pharmaceutical applications and gene regulation studies. Its exceptional utility extends to therapeutic strategies in genetic disorders and cancer treatment development. Synonyms: 5'-Dimethoxytrityl-N6-dimethylaminomethylidene-8-aza-7-deaza-Adenosine, 2'-O-TBDMS-3'-[(2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite. Molecular formula: C49H67N8O7PSi. Mole weight: 939.16. | |
| 8-Azaadenine | 8-Azaadenine is a xanthine oxidase (XAO) inhibitor (IC50 = 0.54 μM, Ki = 0.66 μM). Synonyms: 3H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine; 1H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine; 1H-v-Triazolo[4,5-d]pyrimidine, 7-amino-; 6-Amino-8-azapurine; 7-Amino-1-v-triazolo[d]pyrimidine; 7-Amino-v-triazolo[d]pyrimidine; 8-Aza-6-aminopurine; NSC 32797. Grade: 95%. CAS No. 1123-54-2. Molecular formula: C4H4N6. Mole weight: 136.11. | |
| 8-Azaadenine | 8-Azaadenine. Group: Biochemicals. Grades: Highly Purified. CAS No. 1123-54-2. Pack Sizes: 1g, 2g, 5g. US Biological Life Sciences. | Worldwide |
| 8-Azaadenosine | 8-Azaadenosine is a potent ADAR1 inhibitor and an A-to-I editing inhibitor. 8-Azaadenosine blocks RNA editing and inhibits proliferation, 3D growth, invasion, and migration in thyroid cancer cells[1][2]. Uses: Scientific research. Group: Signaling pathways. CAS No. 10299-44-2. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-115686. |  |
| 8-Azaadenosine | 10mg Pack Size. Group: Analytical Reagents, Biochemicals. Formula: C9H12N6O4. CAS No. 10299-44-2. Prepack ID 62830545-10mg. Molecular Weight 268.23. See USA prepack pricing. |  |
| 8-Azaadenosine | 8-Azaadenosine, an exquisitely potent and remarkably discriminating inhibitor of adenosine kinasean instrumental enzyme governing the intricate regulation of the purine nucleoside reservoirholds undeniable significance in the realm of biomedical exploration. Its application in scientific inquiry is instrumental in disentangling the intricate web of adenosine kinase's involvement in multifarious physiological states, notably encompassing cancer, epilepsy, and inflammation. Synonyms: 7-Amino-3-β-D-ribofuranosyl-v-triazolo[4,5-d]pyrimidine; 3-β-D-Ribofuranosyl-3H-1,2,3-triazolo[4,5-d]pyrimidin-7-amine. Grade: ≥ 97%. CAS No. 10299-44-2. Molecular formula: C9H12N6O4. Mole weight: 268.23. | |
| 8-Azaadenosine | 8-Azaadenosine. Group: Biochemicals. Grades: Highly Purified. CAS No. 10299-44-2. Pack Sizes: 10mg, 25mg, 50mg, 100mg, 250mg. Molecular Formula: C9H11N5O5. US Biological Life Sciences. | Worldwide |
| 8-Aza-ATP | 8-Aza-ATP, a powerful and discriminating activator of the P2Y1 receptor, plays a critical role in an array of physiological processes, including platelet aggregation and neuroprotection. Its therapeutic uses have been explored in a litany of conditions, ranging from stroke and traumatic brain injury to glaucoma, and even hold promise for treating cancer via its potent antiproliferative and antitumor qualities. Synonyms: 8-Azaadenosine-5'-Triphosphate. Grade: ≥90% by AX-HPLC. Molecular formula: C9H15N6O13P3. Mole weight: 508.1. | |
| 8-Azabicyclo[3.2.1]oct-2-ene-2-carboxylic Acid 8-Methyl-Ethyl Ester | 8-Azabicyclo[3.2.1]oct-2-ene-2-carboxylic Acid 8-Methyl-Ethyl Ester. Group: Biochemicals. Alternative Names: (-)-Anhydroecgonine Ethyl Ester; (R)-Anhydroecgonine Ethyl Ester; Anhydroecgonine Ethyl Ester; Ecgonidine Ethyl Ester; Ethyl Ecgonidine; Methylecgonidine. Grades: Highly Purified. CAS No. 73045-45-1. Pack Sizes: 25mg. Molecular Formula: C11H17NO2, Molecular Weight: 195.26. US Biological Life Sciences. | Worldwide |
| 8-Azabicyclo[3.2.1]octan-3-ol, 8-methyl-, 8-oxide, hydrochloride (1:1), (3-endo)- | 8-Azabicyclo[3.2.1]octan-3-ol, 8-methyl-, 8-oxide, hydrochloride (1:1), (3-endo)-. Uses: Designed for use in research and industrial production. CAS No. 1234788-77-2. Molecular formula: C8H15NO2.HCl. Mole weight: 193.67. Purity: 0.95. Product ID: ACM1234788772. Alfa Chemistry ISO 9001:2015 Certified. | |
| 8-Azabicyclo[3.2.1]octan-3-one,2-hydroxy-8-methyl-,endo-(9ci) | 8-Azabicyclo[3.2.1]octan-3-one,2-hydroxy-8-methyl-,endo-(9ci). Uses: Designed for use in research and industrial production. Additional or Alternative Names: 8-Azabicyclo[3.2.1]octan-3-one,2-hydroxy-8-methyl-,endo-(9CI). Product Category: Heterocyclic Organic Compound. CAS No. 62251-42-7. Molecular formula: C8H13NO2. Product ID: ACM62251427. Alfa Chemistry ISO 9001:2015 Certified. Categories: 2-HYDROXY-8-METHYL-8-AZABICYCLO[3.2.1]OCTAN-3-ONE. | |
| 8-Azabicyclo[3.2.1]octane-2,3,4-trione,6-methoxy-8-methyl-,2,4-dioxime,(1R,5R,6S)-rel-(9CI) | 8-Azabicyclo[3.2.1]octane-2,3,4-trione,6-methoxy-8-methyl-,2,4-dioxime,(1R,5R,6S)-rel-(9CI). Uses: Designed for use in research and industrial production. Additional or Alternative Names: 8-Azabicyclo[3.2.1]octane-2,3,4-trione,6-methoxy-8-methyl-,2,4-dioxime,(1R,5R,6S)-rel-(9CI). Product Category: Heterocyclic Organic Compound. CAS No. 805183-62-4. Molecular formula: C9H13N3O4. Product ID: ACM805183624. Alfa Chemistry ISO 9001:2015 Certified. | |
| 8-Azabicyclo[3.2.1]octane-2-carboxylicacid,3-(4-iodophenyl)-8-methyl-,methyl ester,(1R,2S,3S,5S)- | 8-Azabicyclo[3.2.1]octane-2-carboxylicacid,3-(4-iodophenyl)-8-methyl-,methyl ester,(1R,2S,3S,5S)-. Uses: Designed for use in research and industrial production. Additional or Alternative Names: CAINDEXNAME:8-AZABICYCLO[3.2.1]OCTANE-2-CARBOXYLIC;(()-2-beta-Carbomethoxy-3-beta-(4-iodophenyl)tropane;8-Azabicyclo[3.2.1]octane-2-carboxylic acid, 3-(4-iodophenyl)-8-methyl, methyl ester, (1R,2S,3S,5S)-;(1R,2S,3S,5S)-3-(4-Iodophenyl)tropane-2-carboxyli. Product Category: Heterocyclic Organic Compound. CAS No. 135416-43-2. Molecular formula: C16H20INO2. Mole weight: 385.24. Density: 1.493 g/cm48. Product ID: ACM135416432. Alfa Chemistry ISO 9001:2015 Certified. Categories: Iometopane. | |
| 8-Azabicyclo[3.2.1]octane-2-carboxylicacid,3-(4-iodophenyl)-,methyl ester,(1R,2S,3S,5S)- | 8-Azabicyclo[3.2.1]octane-2-carboxylicacid,3-(4-iodophenyl)-,methyl ester,(1R,2S,3S,5S)-. Uses: Designed for use in research and industrial production. Additional or Alternative Names: Nor-beta-cit, N-Nor-cit, CID131993, N-Nor-3-(4-iodophenyl)tropane-2-carboxylic acid methyl ester, 136794-87-1, 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(4-iodophenyl)-, methyl ester, (1R-(exo,exo))-. Product Category: Heterocyclic Organic Compound. CAS No. 136794-87-1. Molecular formula: C15H18INO2. Mole weight: 371.21. Purity: 0.96. IUPACName: methyl (5R)-3-(4-iodophenyl)-8-azabicyclo[3.2.1]octane-4-carboxylate. Canonical SMILES: COC(=O)C1C2CCC(N2)CC1C3=CC=C(C=C3)I. Density: 1.528g/cm³. Product ID: ACM136794871. Alfa Chemistry ISO 9001:2015 Certified. | |
| 8-Aza-cAMP | 8-Aza-cAMP is a paramount compound manifesting as a chemical mimic of cyclic adenosine monophosphate (cAMP). This compound exerts preferential impediment upon the aberrant proliferation of neoplastic cells. Synonyms: 8- Azaadenosine- 3', 5'- cyclic monophosphate. CAS No. 67190-31-2. Molecular formula: C9H10N6O6P · Na. Mole weight: 352.2. | |
| 8-Azaguanine | 8-Azaguanine is a purine analogue that shows antineoplastic activity. 8-Azaguanine functions as an antimetabolite and easily incorporates into ribonucleic acids, interfering with normal biosynthetic pathways, thus inhibiting cellular growth [1]. Uses: Scientific research. Group: Natural products. CAS No. 134-58-7. Pack Sizes: 100 mg; 500 mg. Product ID: HY-B1468. | |
| 8-Azaguanine | 8-Azaguanine. Group: Biochemicals. Alternative Names: Guanazolo. Grades: Highly Purified. CAS No. 134-58-7. Pack Sizes: 250mg, 500mg, 1g, 2g, 5g. Molecular Formula: C4H4N6O. US Biological Life Sciences. | Worldwide |
| 8-Azaguanine | It is produced by the strain of Str. albus var. pathocidicus. It is a nitrogen-containing heterocyclic antifungal antibiotic. 8-azaguanine functions as an antimetabolite and easily incorporates into ribonucleic acids, interfering with normal biosynthetic pathways, thus inhibiting cellular growth. Synonyms: Pathocidin; 5-Amino-1H-vic-triazolo[d]pyrimidin-7-ol; 5-Amino-7-hydroxy-1H-v-triazolo[d]pyrimidine; 5-Amino-3,6-dihydro-7H-1,2,3-triazolo[4,5-d]pyrimidin-7-one; 8-AG; Azaguanine; Azan; Guanazol; Guanazolo; NSC 151069; NSC 223526; NSC 749; Pathocidine. Grade: ≥97%. CAS No. 134-58-7. Molecular formula: C4H4N6O. Mole weight: 152.11. | |
| 8-Azaguanine | Azaguanine. CAS No. 134-58-7. |  Pennsylvania PA |
| 8-Azaguanosine | 8-Azaguanosine is a modified nucleoside where a nitrogen atom replaces the carbon at the eighth position of the guanine base. This alteration can impact base pairing and hydrogen bonding properties. It is used in biochemical and molecular biology research to study nucleic acid interactions, enzyme activity, and the structural effects of nucleobase modifications. Additionally, 8-azaguanosine is investigated for its potential antiviral and anticancer properties due to its ability to interfere with nucleic acid metabolism. Synonyms: Azaguanosine; NSC 46788; NSC 130283; 5-Amino-3,6-dihydro-3-β-D-ribofuranosyl-7H-1,2,3-triazolo[4,5-d]pyrimidin-7-one; 3H-v-Triazolo[4,5-d]pyrimidin-7(6H)-one, 5-amino-3-β-D-ribofuranosyl-; 3H-v-Triazolo[4,5-d]pyrimidin-7-ol, 5-amino-3-β-D-ribofuranosyl-; 7H-1,2,3-Triazolo[4,5-d]pyrimidin-7-one, 5-amino-3,4-dihydro-3-β-D-ribofuranosyl-; 7H-v-Triazolo[4,5-d]pyrimidin-7-one, 5-amino-3,6-dihydro-3-β-D-ribofuranosyl-. Grade: ≥95%. CAS No. 2133-80-4. Molecular formula: C9H12N6O5. Mole weight: 284.23. | |
| 8-Azahypoxanthine | 8-Azahypoxanthine is an antimalarial agent that inhibits hypoxanthine-guanine-xanthine phosphoribosyl transferase. Synonyms: 7H-1,2,3-Triazolo[4,5-d]pyrimidin-7-one, 3,6-dihydro-; 3,6-Dihydro-7H-1,2,3-triazolo[4,5-d]pyrimidin-7-one; 7H-1,2,3-Triazolo[4,5-d]pyrimidin-7-one, 1,4-dihydro-; 7H-v-Triazolo[4,5-d]pyrimidin-7-one, 1,6-dihydro-; 1H,4H,7H-[1,2,3]Triazolo[4,5-d]pyrimidin-7-one; 1H-1,2,3-Triazolo[4,5-d]pyrimidin-7-ol; 1H-v-Triazolo[4,5-d]pyrimidin-7-ol; 2,3-Dihydrotriazolo[4,5-d]pyrimidin-7-one; 7-Hydroxy-1,2,3,4,6-pentaazaindene; 7-Hydroxy-v-triazolo[d]pyrimidine; NSC 22709. Grade: ≥95%. CAS No. 2683-90-1. Molecular formula: C4H3N5O. Mole weight: 137.10. | |
| 8-Azanebularine | 8-Azanebularine, a compound with hydrogen in place of the C6 amino group, inhibits the ADAR2 reaction at high concentrations (IC50=15 mM). 8-Azanebularine is incorporated into an RNA structure recognized by human ADAR2 results in high-affinity binding (KD=2 nM). 8-Azanebularine can be used for the research of ADAR-catalyzed RNA-editing reaction[1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 38874-46-3. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg. Product ID: HY-145442. | |
| 8-Azanebularine CE-Phosphoramidite | DMTr-2'-O-TBDMS-8-azanebularine-3'-CE-Phosphoramidite is a chemical compound used in oligonucleotide synthesis. It protects the 5'-hydroxyl group with a DMTr group and stabilizes the ribose sugar with a 2'-O-TBDMS modification. Additionally, it incorporates 8-azanebularine as a modified nucleoside. The 3'-CE phosphoramidite facilitates nucleotide addition during synthesis. This compound allows for the controlled synthesis of oligonucleotides with specific modifications, important for various applications in molecular biology and biotechnology. Synonyms: DMTr-2'-O-TBDMS-8-azanebularine-3'-CE-Phosphoramidite. Grade: ≥95%. CAS No. 771494-03-2. Molecular formula: C45H60N7O7PSi. Mole weight: 870.08. | |
| 8-Azatricyclo[4.3.0.01,4]nonane(9ci) | 8-Azatricyclo[4.3.0.01,4]nonane(9ci). Uses: Designed for use in research and industrial production. Additional or Alternative Names: 8-Azatricyclo[4.3.0.01,4]nonane(9CI). Product Category: Heterocyclic Organic Compound. CAS No. 484032-29-3. Molecular formula: C8H13N. Product ID: ACM484032293. Alfa Chemistry ISO 9001:2015 Certified. | |
| 8-Azaxanthine monohydrate | 8-Azaxanthine monohydrate. Group: Biochemicals. Grades: Highly Purified. CAS No. 59840-67-4. Pack Sizes: 1g, 2g, 5g. Molecular Formula: C4H3N5O2·H2O. US Biological Life Sciences. | Worldwide |
| 8-Azido-2'-deoxyadenosine | 8-Azido-2'-deoxyadenosine is a potent nucleoside analogue extensively for its ability to selectively inhibit DNA enhancement. This versatile compound finding application in the research of various diseases, including cancers and viral infections. Synonyms: (2R,3S,5R)-5-(6-amino-8-azido-9H-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol; Adenosine, 8-azido-2'-deoxy-. Grade: ≥95%. CAS No. 131265-35-5. Molecular formula: C10H12N8O3. Mole weight: 292.17. | |
| 8-Azido-2'-deoxyadenosine | 8-Azido-2'-deoxyadenosine. Group: Biochemicals. Grades: Highly Purified. CAS No. 131265-35-5. Pack Sizes: 2mg, 5mg, 10mg, 25mg, 50mg. Molecular Formula: C10H12N8O3. US Biological Life Sciences. | Worldwide |
| 8-Azido-2'-deoxyadenosine | 8-Azido-2'-deoxyadenosine. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 8-AZIDO-2'-DEOXYADENOSINE. Product Category: Heterocyclic Organic Compound. CAS No. 131265-35-5. Molecular formula: C10H12N8O3. Mole weight: 292.25. Product ID: ACM131265355. Alfa Chemistry ISO 9001:2015 Certified. | |
| 8-Azido-3,6-dioxa-1-octanol mesylate | 8-Azido-3,6-dioxa-1-octanol mesylate. Uses: Designed for use in research and industrial production. Additional or Alternative Names:1-azido-11-(methylsulfonyl)oxy-3,6,9-trioxaundecane.tetra(ethyleneglycol) azido mesylate.2-(2-(2-(2-azidoethoxy)ethoxy)ethoxy)ethyl methane sulfonate; 2-(2-(2-(2-azidoethoxy)ethoxy)ethoxy)ethyl mono-methanesulphonate; 8-Azido-3,6-dioxa-1-octanol mesy. Product Category: Heterocyclic Organic Compound. CAS No. 134179-43-4. Molecular formula: C7H15N3O5S. Mole weight: 253.28. Purity: 0.96. IUPACName: methanesulfonic acid 2-{2-[2-(2-azidoethoxy)ethoxy]ethoxy}ethyl ester. Product ID: ACM134179434. Alfa Chemistry ISO 9001:2015 Certified. | |
| 8-Azido-3,6-dioxaoctanoic acid cyclohexylammonium salt | 8-Azido-3,6-dioxaoctanoic acid cyclohexylammonium salt. Synonyms: Azido-PEG2-acetic Acid CHA Salt; 2-[2-(2-Azidoethoxy)ethoxy]acetic Acid Cyclohexylamine Salt; [2-(2-azidoethoxy)ethoxy]acetic acid cyclohexylamine salt; N3-AEEA CHA; Acetic acid, 2-[2-(2-azidoethoxy)ethoxy]-, compd. with cyclohexanamine (1:1); N3 AEEA CHA. Grade: ≥ 99% (HPLC). CAS No. 2098500-94-6. Molecular formula: C12H24N4O4. Mole weight: 288.34. | |
| 8-Azido-3,6-dioxaoctanoic acid tert-butyl ester | Azido-PEG2-C1-Boc is a polyethylene glycol (PEG)-based PROTAC linker. Azido-PEG2-C1-Boc can be used in the synthesis of a series of PROTACs. Synonyms: Azido-PEG2-CH2CO2tBu; N3-AEEA-OtBu; tert-butyl 8-azido-3,6-dioxaoctanoate; Azido-PEG2-C1-Boc; N3-PEG2-CH2COOtBu; Azido-PEG2-CH2CO2-t-Bu; tert-butyl 2-[2-(2-azidoethoxy)ethoxy]acetate; N3 AEEA OtBu. Grade: ≥ 95% (GC). CAS No. 251564-45-1. Molecular formula: C10H19N3O4. Mole weight: 245.28. | |
| 8-Azido-3,6-dioxaoctanoyl-AEEA | 8-Azido-3,6-dioxaoctanoyl-AEEA. Synonyms: N3-AEEA-AEEA; 8-(8-Azido-3,6-dioxaoctanoylamido)-3,6-dioxaoctanoic acid; 2-[2-[2-[[2-[2-(2-Azidoethoxy)ethoxy]acetyl]amino]ethoxy]ethoxy]acetic acid. Grade: 99-100% (Assay by titration). CAS No. 1254054-60-8. Molecular formula: C12H22N4O7. Mole weight: 334.30. | |
| 8-Azidoadenosine | 8-Azidoadenosine. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 50mg. US Biological Life Sciences. | Worldwide |
| 8-Azido-adenosine | 8-Azido-adenosine, a highly versatile compound employed extensively in the realm of biomedical research, serves as an invaluable vehicle for investigating intricate nucleotide metabolism and underlying biological processes. Renowned for its prowess as a tool compound, it ensures precise nucleoside labeling, facilitates comprehensive enzymatic studies, and facilitates the unmasking of intricate protein-protein interactions. The azido functional group it harbors empowers researchers to venture into the realm of bioorthogonal chemistry, enabling thorough exploration of diverse drug targets and mechanisms intricately tied to the realm of disease. Synonyms: 8-Azidoadenosine; (2R,3R,4S,5R)-2-(6-amino-8-azido-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; 8-Azido Adenosine. Grade: ≥95% by HPLC. CAS No. 4372-67-2. Molecular formula: C10H12N8O4. Mole weight: 308.25. | |
| 8-Azidoadenosine 3',5'-cyclic monophosphosphate free acid | 8-Azidoadenosine 3',5'-cyclic monophosphosphate free acid. Group: Biochemicals. Grades: Highly Purified. CAS No. 31966-52-6. Pack Sizes: 1mg, 2mg, 5mg. Molecular Formula: C10H11N8O6P. US Biological Life Sciences. | Worldwide |
| 8-Azidoadenosine 5'-monophosphate sodium salt | 8-Azidoadenosine 5'-monophosphate sodium salt is a biomedical compound commonly used in drug discovery and development. This product plays a vital role in studying the detailed mechanisms of various diseases, including cancer, viral infections, and neurological disorders. By acting as a precursor to adenosine triphosphate (ATP), it aids in investigating and evaluating potential therapeutic targets and drug candidates for these conditions. CAS No. 60731-47-7. Molecular formula: C10H13N8O7P. Mole weight: 388.23. | |
| 8-Azidoadenosine-5'-Triphosphate | 8-Azidoadenosine-5'-Triphosphate is a crucial tool in compound for studying ATP-dependent processes. With its azido group, it enables selective photo-crosslinking to ATP-binding proteins and subsequent identification. Widely used in drug discovery and proteomics, it aids in investigating ATP-dependent diseases like cancer and neurodegenerative disorders. Uses: Affinity labels. Synonyms: 8-Azido-ATP; 8-Azidoadenosine 5'-(tetrahydrogen triphosphate); 8-Azido ATP; 8-Azidoadenosine 5'-triphosphate; 8-Azidoadenosine triphosphate. Grade: ≥90% by AX-HPLC. CAS No. 53696-59-6. Molecular formula: C10H15N8O13P3. Mole weight: 548.19. | |
| 8-Azidoadenosine 5-triphosphate,sodium salt | 8-Azidoadenosine 5-triphosphate,sodium salt. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 8-azidoadenosine-5'-o-triphosphate(8-n3-atp),sodiumsalt;8-azidoadenosine5'-triphosphate;8-azidoadenosine5'-triphosphatesodium;8-AZIDOADENOSINE 5-TRIPHOSPHATE, SODIUM SALT;8-AZIDOADENOSINE-5-O-TRIPHOSPHATE SODIUM SALT;8-N3-ATP SODIUM SALT;8-Azido-D-adenosine5-triphosphatesodiumsalt;Adenosine 5-(tetrahydrogen triphosphate), 8-azido-. CAS No. 53696-59-6. Molecular formula: C10H14N8NaO13P3. Mole weight: 570.17. Purity: 95+%. IUPACName: sodium;[[[(2R,3S,4R,5R)-5-(6-amino-8-azidopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]hydrogenphosphate. Canonical SMILES: C1=NC2=C(C(=N1)N)N=C(N2C3C(C(C(O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)[O-])O)O)N=[N+]=[N-].[Na+]. Product ID: ACM53696596. Alfa Chemistry ISO 9001:2015 Certified. | |
| 8-Azidoadenosine 5'-triphosphate sodium salt | 8-Azidoadenosine 5'-triphosphate sodium salt. Group: Biochemicals. Grades: Highly Purified. CAS No. 53696-59-6. Pack Sizes: 2.5mg, 5mg, 10mg, 25mg. Molecular Formula: C10H12N8O13P3·Na3. US Biological Life Sciences. | Worldwide |
Our database is helping our users find suppliers everyday.
